Key result
Diagnostic arteriography is linked to a ~6-fold increase in autopsy-detected cholesterol embolization.
Why the study?
Cholesterol embolization is not widely recognized as a complication of major arteriographic procedures.
Do diagnostic arteriographic procedures increase the incidence of cholesterol embolization compared to matched controls?
Observational (n=71)
Do diagnostic arteriographic procedures increase the incidence of cholesterol embolization compared to matched controls?
Diagnostic arteriographic procedures are associated with a significantly higher incidence of cholesterol embolization at autopsy compared to matched controls.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to underrecognized embolization risk after arteriography; hypothesis-generating pending prospective confirmation.
Cholesterol embolization is not widely recognized as a complication of major arteriographic procedures. In a retrospective study of 71 autopsies of patients who underwent diagnostic arteriographic procedures (20 with aortograms, 51 with cardiac catheterization and coronary angiography), we found an incidence of cholesterol embolization of 30% and 25.5%, respectively, in comparison with 4.3% in an age and disease-matched control population. The organs most frequently affected are the kidney and spleen following aortogram, and the myocardium following cardiac catheterization. The clinical importance of these findings cannot be ascertained from this study, but our experience with a single case demonstrates that radiographic studies may produce substantial morbidity.
No takes yet. Share an insight, caveat, or question.
G. Ramirez (1978) conducted an observational in Patients undergoing diagnostic arteriographic procedures (n=71). Diagnostic arteriographic procedures vs. Age and disease-matched control population was evaluated on Incidence of cholesterol embolization. Diagnostic arteriographic procedures were associated with a 25.5-30% incidence of cholesterol embolization at autopsy, compared to 4.3% in an age- and disease-matched control population.
Synapse has enriched 10 related papers. Consider them for comparative context: